Pure Global AI
CDSCO UID IMP/IVD/2022/000152_f4bee0fbf1c48130b5704bd53bbced76_d968e9a876bde809c9f36893e2680c9b

Anti-Cardiolipin ELISA

M/s. CPC Diagnostics Pvt LtdDevice Class Class BIndia CDSCOBrand: NIL
VerifiedCDSCO · official registry
Registration details
UID
IMP/IVD/2022/000152_f4bee0fbf1c48130b5704bd53bbced76_d968e9a876bde809c9f36893e2680c9b
Device class
Class B
Brand name
NIL
Approving authority
CDSCO
Product information
The ELISA test kit provides a semiquantitative or quantitative in vitro assay for human autoantibodies of the IgAGM class against cardiolipin in serum or plasma for the diagnosis of anti-phospholipid syndrome (NIL)
About this record

Anti-Cardiolipin ELISA is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000152_f4bee0fbf1c48130b5704bd53bbced76_d968e9a876bde809c9f36893e2680c9b. This device is marketed under the brand name NIL. The license holder is M/s. CPC Diagnostics Pvt Ltd, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides the facts attached to this CDSCO registry row. Other records from the same license holder are available through the database search link without adding aggregation queries to this page. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.